Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jan;24(1):165-77, x.
doi: 10.1016/j.ccc.2007.10.004.

Mechanisms of neuromuscular dysfunction in critical illness

Affiliations
Review

Mechanisms of neuromuscular dysfunction in critical illness

Jaffar Khan et al. Crit Care Clin. 2008 Jan.

Abstract

The development of neuromuscular dysfunction (NMD) during critical illness is increasingly recognized as a cause of failure to wean from mechanical ventilation and is associated with significant morbidity and mortality. At times, it is difficult to identify the presence of NMD and distinguish the etiology of the weakness in patients with critical illness, but subtle clinical findings and bedside electrophysiologic testing are helpful in establishing the diagnosis. This article describes the clinical spectrum of acquired neuromuscular weakness in the setting of critical illness, provides an approach to diagnosis, and discusses its pathogenesis. Finally, a defective sodium channel regulation as a unifying mechanism underlying NMD in critically ill patients is proposed.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to report.

References

    1. MacFarlane IA, Rosenthal FD. Rosenthal, Severe myopathy after status asthmaticus [letter] Lancet. 1977;2(8038):615. - PubMed
    1. Hirano M, Ott BR, Raps EC, et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both [see comments] Neurology. 1992;42(11):2082–2087. - PubMed
    1. Larsson L, Li X, Edstrom L, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med. 2000;28(1):34–45. - PubMed
    1. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle & Nerve. 1991;14(11):1131–1139. - PubMed
    1. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32(2):140–163. - PubMed

Publication types

MeSH terms